Lonsurf 20 MG-8.19 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM2XU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,044
Award facts
- Contract value 100% obligated
- $11,043.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Lonsurf (a cancer treatment medication) in the form of 20 mg-8.19 mg tablets, quantity 60 units, with a ceiling value of $11,043.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 12, 2026. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
This contract supports the Defense Logistics Agency's medical supply chain operations, which provides pharmaceutical products to military treatment facilities, veteran healthcare programs, and other federal medical institutions. AmerisourceBergen serves as a critical pharmaceutical distributor for federal agencies, supplying a comprehensive range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. The firm fixed-price structure and competitive award reflect AmerisourceBergen's established capability to meet federal procurement requirements for essential pharmaceutical commodities supporting the Department of Defense's healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FM2XU?
SPE2DR26FM2XU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FM2XU worth?
The government has obligated $11,044 on SPE2DR26FM2XU.
Is contract SPE2DR26FM2XU an order under another contract?
Yes. SPE2DR26FM2XU is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2XU competed?
The extent of competition for SPE2DR26FM2XU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award